Prediction of peanut allergy in adolescence by early childhood storage protein-specific IgE signatures: the BAMSE population-based birth cohort
|
|
- Benjamin Gibson
- 5 years ago
- Views:
Transcription
1 Accepted Manuscript Prediction of peanut allergy in adolescence by early childhood storage protein-specific IgE signatures: the BAMSE population-based birth cohort Anna Asarnoj, MD, PhD, Carl Hamsten, PhD, Christian Lupinek, MD, PhD, Erik Melén, MD, PhD, Niklas Andersson, MSc, Josep M. Anto, MD, PhD, Jean Bousquet, MD, PhD, Rudolf Valenta, MD, Marianne van Hage, MD, PhD, Magnus Wickman, MD, PhD PII: S (17)30221-X DOI: /j.jaci Reference: YMAI To appear in: Journal of Allergy and Clinical Immunology Received Date: 21 June 2016 Revised Date: 12 December 2016 Accepted Date: 19 December 2016 Please cite this article as: Asarnoj A, Hamsten C, Lupinek C, Melén E, Andersson N, Anto JM, Bousquet J, Valenta R, van Hage M, Wickman M, Prediction of peanut allergy in adolescence by early childhood storage protein-specific IgE signatures: the BAMSE population-based birth cohort, Journal of Allergy and Clinical Immunology (2017), doi: /j.jaci This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
2 Asarnoj et al Prediction of peanut allergy in adolescence by early childhood storage protein-specific IgE signatures: the BAMSE population-based birth cohort Anna Asarnoj, MD, PhD 1,2, Carl Hamsten*, PhD 1, Christian Lupinek*, MD, PhD 3, Erik Melén, MD, PhD 4,5, Niklas Andersson, MSc 4, Josep M Anto, MD, PhD 6,7,8,9, Jean Bousquet, MD, PhD 10, Rudolf Valenta, MD 3, Marianne van Hage, MD, PhD 1,, Magnus Wickman, MD, PhD 4,5,11 * shared second authorship shared last authorship 1. Immunology and Allergy Unit, Department of Medicine, Karolinska Institutet, and Karolinska University Hospital, Stockholm, Sweden 2. Astrid Lindgren Children s Hospital, Karolinska University Hospital, Stockholm, Sweden 3. Division of Immunopathology, Department of Pathophysiology and Allergy Research, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Austria 4. Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden 5. Dept. of Pediatrics, Sachs Children s Hospital, Stockholm, Sweden 6. ISGlobal, Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain 7. IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain 8. Universitat Pompeu Fabra (UPF), Barcelona, Spain 9. CIBER Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain 10. University Hospital, Montpellier, France; INSERM, VIMA : Ageing and chronic diseases. Epidemiological and public health approaches, U1168, Paris; UVSQ, UMR-S 1168, Université Versailles St- Quentin-en-Yvelines, France Centre for Allergy Research, Karolinska Institutet, Stockholm, Sweden 1
3 Asarnoj et al Short title: Evolution of peanut allergy during childhood Corresponding author: Anna Asarnoj, MD, PhD Immunology and Allergy Unit, L2:04, Department of Medicine Karolinska Institutet and University Hospital S Stockholm, Sweden Telephone: Fax: Key words Peanut allergy; allergen; Ara h 2; component resolved diagnostics; IgE; molecular allergology; sensitization; birth cohort; BAMSE Funding Supported by the Swedish Asthma and Allergy Research Foundation; Stockholm County Council; the Swedish Research Council of Health, Working Life and Welfare; the Swedish Research Council, the Swedish Society of Medicine, the Swedish Heart-Lung Foundation; the Swedish Cancer and Allergy Foundation; the Konsul Th Berg s Foundation, the Magnus Bergvall Foundation, the Swedish Association for Allergology, the European Commission s Seventh Framework 29 Program MeDALL under grant agreement no , and in part by grant F4605 of the Austrian Science Fund (FWF). 50 2
4 Asarnoj et al Author Contributions Data acquisition: AA, CL, EM, NA, RV, MvH, MW; Technical support: CH, CL, NA, RV; Material support: CL, RV, MvH; Manuscript writing: AA, CH, MvH, MW; Critical revision of the manuscript: EM, JA, JB, RV; Study supervision: EM, MvH, MW 3
5 Asarnoj et al Abbreviations Ara h: Arachis hypogaea PR-10: Pathogenesis-related protein family 10 LTP: Lipid transfer protein 95% CI: 95% Confidence interval OAS: Oral allergy syndrome DBPCFC: Double-blind placebo-controlled food challenge 4
6 Asarnoj et al Capsule summary (34 words) IgE signatures to peanut allergen measured in early childhood allow predicting the likelihood of peanut allergy in adolescence. Peanut symptoms and Ara h 2 IgE >2.0 ISU-E at 4 years predict peanut allergy in adolescence. 5
7 Asarnoj et al 71 To the Editor: One of the most frequent and severe forms of food allergy is caused by peanuts 1. IgE reactivity to peanut storage proteins, in particular to Ara h 2, is associated with systemic reactions 2. However, in some regions the lipid transfer protein Ara h 9 is an important allergen molecule whereas in birch endemic areas, the PR-10 protein Ara h 8 is a more common cross-reactive component 3. In the Isle of Wight birth cohort, peanut allergy showed an early onset 4. Interestingly, the percentage of symptomatic patients did not increase but an increase in peanut extract sensitization was noted until adolescence 4. The development of IgE antibody reactivity to the different peanut allergen molecules as well as how IgE sensitization to these molecules contributes to development of peanut symptoms has not yet been explored. In this study, the evolution of sensitization to peanut allergen molecules from early childhood to adolescence was investigated for the first time. We used a random subset of 778 children from the Swedish BAMSE birth cohort (N=4089) 5 where complete relevant questionnaire data from baseline (2 months), 1, 2, 4, 8 and 16 years and blood samples from 4, 8 and 16 years were available. For some of the analyses, this population-based study group was enriched with additional 84 peanut extract-sensitized children (at 4, 8 and/or 16 years) from the same cohort. Thus, our peanut-enriched study group included 862 children (778 from the populationbased study group enriched with 84 peanut sensitized children) (Figure E1). Serum samples were analyzed for IgE antibodies to peanut extract, and at 8 years of age also to Ara h 2, by ImmunoCAP (Thermo Fisher AB, Uppsala, Sweden) and for peanut allergen molecules (Ara h 1, h 2, h 3, h 6, h 8 and h 9) using a modified allergen chip based on ISAC technology (Thermo Fisher) 5. The correlation factor (rho) between the IgE levels to Ara h 2 at 8 years measured with microarray and ImmunoCAP was high: A linear regression with ImmunoCAP and microarray Ara h 2 IgE levels was performed to calculate corresponding values. Detailed information on methods and statistics is provided in the Online Repository at In the population-based study group, the frequencies of sensitization to storage proteins showed little change from 4 to 16 years, but sensitization to the birch pollen homologous allergen molecule Ara h 8 increased at each time point (Figures 1A and 1B). Any reported systemic symptom to peanut in combination with peanut storage protein sensitization increased from 1.4% at 8 years to 3.0% at 16 6
8 Asarnoj et al years (p=0.03, Table E1). The prevalence rates and trajectories, i.e. onset, persistence and transition of IgE reactivity, as well as IgE-levels to peanut extract and the different peanut allergen molecules are displayed in Figures 1A and 1B. Due to the substantial overlap of sensitization to the peanut storage proteins (Figures E2 and E3), no multivariate logistic regression estimates for IgE reactivity to each storage protein in relation to allergic symptoms to peanut could be performed. Of the 54 Ara h 2-sensitized children at 16 years in the peanutenriched study group, 45 (83%) were already sensitized at 4 years and 49 (91%) reported symptoms to peanut at 16 years. Only one participant had de novo Ara h 2 sensitization (0.8 ISU-E) after 8 years (data not shown). The high rate of storage protein sensitization at 4 years among children developing peanut allergy during the first 16 years of life raises the important question of prevention. In children with both peanut and birch pollen sensitization, one fraction was mono-sensitized to Ara h 8 (Figure 2). These children reported no peanut symptoms or only oral allergy syndrome (OAS) at 16 years of age. We have previously reported that sensitization to Ara h 8 is associated with mild OAS or peanut tolerance 6. Interestingly in this study, most children with onset of peanut sensitization after 4 years had IgE reactivity to Ara h 8 only and not to the storage peanut proteins, and were mostly asymptomatic or without report of any systemic symptoms 4, 6. Another fraction of children was sensitized to Ara h 2 (regardless co-sensitization to Ara h 8). At 16 years, peanut symptoms at exposure were reported in 91% of these Ara h 2 sensitized participants. The predicted longitudinal likelihood of reporting peanut allergy at 16 years in the peanut-enriched study group (n=862) was plotted in relation to IgE-levels to Ara h 2 (Figure E4A, incident symptoms Figure E4B), peanut extract (Figure E4C) as well as to the number of sensitizing peanut allergen molecules 4 years of age (Figure E4D). An IgE-level of >2.0 ISU-E to Ara h 2, >15.5 ku A /L to peanut extract or IgE reactivity ( 0.3 ISU-E) to at least 4 peanut allergen molecules at 4 years of age corresponded to a 95% likelihood of reporting peanut symptoms 12 years later. Due to the large number of children investigated in the BAMSE cohort it was not possible to verify peanut symptoms with the double-blind placebo-controlled food challenge (DBPCFC). However, the calculated longitudinal peanut extract-specific IgE level at 4 years (15.5 ku A /L) with a 95% likelihood of peanut symptoms at 16 years is very similar to the one reported in a cross-sectional clinical study by Sampson and colleagues (15 ku A /L) where DBPCFC were included 7. Several previous DBPCFC studies 7
9 Asarnoj et al demonstrate that even low Ara h 2 IgE-levels are associated with peanut allergy in almost all cases, which was shown in our study as well although most other studies measured Ara h 2 IgE with the ImmunoCAP method 2, 7, 8. As the results in ISAC are semiquantitative and may be influenced by blocking IgG antibodies, they cannot simply be transferred to ImmunoCAP. We made a comparison with ImmunoCAP values at 8 years of age and in the BAMSE cohort, an Ara h 2 level of 2.0 ISU-E in microarray corresponded to 4.1 ku/l in ImmunoCAP (data not shown). In summary, our study is the first to examine the onset and persistence of IgE sensitization to peanut allergen molecules in relation to peanut symptoms from preschool age to adolescence. We identified two distinct phenotypes in the development of peanut allergy from childhood to adolescence. One phenotype develops early in life and is related to Ara h 2 sensitization and risk of systemic reactions after peanut exposure. Children with this phenotype rarely outgrow their symptoms. The second phenotype, which starts later in childhood, is related to Ara h 8 sensitization and non-systemic reactions after peanut ingestion. Furthermore, we show that in preschool children, Ara h 2 sensitization or polysensitization to peanut storage proteins are superior in predicting peanut allergy in adolescence compared to peanut extract sensitization. We suggest that measuring IgE to peanut allergen molecules may help clinicians improve the diagnosis and prognosis of peanut allergy. Acknowledgements We would like to thank all participating families and the staff in the BAMSE study as well as the staff at the laboratory of Professor Rudolf Valenta. Thermo Fisher Scientific kindly provided the ImmunoCAP singleplex reagents for the study. Anna Asarnoj, MD, PhD Carl Hamsten*, PhD Christian Lupinek*, MD, PhD Erik Melén, MD, PhD Niklas Andersson, MSc Josep M Anto, MD, PhD 8
10 Asarnoj et al Jean Bousquet, MD, PhD Rudolf Valenta, MD Marianne van Hage, MD, PhD Magnus Wickman, MD, PhD on behalf of the MeDALL consortium * shared second authorship shared last authorship 9
11 Asarnoj et al References 1. Valenta R, Hochwallner H, Linhart B, Pahr S. Food allergies: the basics. Gastroenterology 2015; 148: e4. 2. Nicolaou N, Murray C, Belgrave D, Poorafshar M, Simpson A, Custovic A. Quantification of specific IgE to whole peanut extract and peanut components in prediction of peanut allergy. J Allergy Clin Immunol 2011; 127: Vereda A, van Hage M, Ahlstedt S, Ibanez MD, Cuesta-Herranz J, van Odijk J, et al. Peanut allergy: Clinical and immunologic differences among patients from 3 different geographic regions. J Allergy Clin Immunol 2011; 127: Arshad SH, Venter C, Roberts G, Dean T, Kurukulaaratchy R. The natural history of peanut sensitization and allergy in a birth cohort. J Allergy Clin Immunol 2014; 134: e6. 5. Lupinek C, Wollmann E, Baar A, Banerjee S, Breiteneder H, Broecker BM, et al. Advances in allergen-microarray technology for diagnosis and monitoring of allergy: the MeDALL allergenchip. Methods 2014; 66: Asarnoj A, Nilsson C, Lidholm J, Glaumann S, Ostblom E, Hedlin G, et al. Peanut component Ara h 8 sensitization and tolerance to peanut. J Allergy Clin Immunol 2012; 130: Sampson HA. Utility of food-specific IgE concentrations in predicting symptomatic food allergy. J Allergy Clin Immunol 2001; 107: Eller E, Bindslev-Jensen C. Clinical value of component-resolved diagnostics in peanut-allergic patients. Allergy 2013; 68: Figure legends Figure 1. Evolution of sensitization (IgE 0.3 ISU-E or 0.35 ku/l, respectively) prevalence (A) and IgElevels among sensitized individuals (B) to peanut allergen molecules and peanut extract at 4, 8 and 16 years of age in a population-based study group. N=778. Footnote: 1A: proportion permanently desensitized if once sensitized to the specific allergen molecule (remission). for comparison with Ara h 8 sensitization; Sensitization rates to birch Bet v 1 were 12.6%, 17.5% and 25.8% at 4, 8 and 16 years of age, respectively B: *IgE levels to peanut allergen molecules and peanut extract did not differ significantly among sensitized individuals in the population-based study group (n=778) compared to the additional peanut extract sensitized participants (n=84). 10
12 Asarnoj et al Figure 2. Peanut and birch pollen extract sensitization overlap measured with ImmunoCAP ( 0.35 ku A /L) at 4, 8 and 16 years of age. Proportion of Ara h 2 sensitization and Ara h 8 monosensitization in the subgroups measured with the MeDALL chip ( 0.3 ISU-E). N=778 (population-based study group) Footnote: *p-values from t-test on log transformed values, not including the 0-values in each symptom subgroup 11
13
14
15
16
17
18
19
20
21
22
23 Asarnoj et al Online Repository text Methods Study participants BAMSE is an unselected population-based birth cohort study of 4089 children 1. For this study, a questionnaire was available from baseline (2 months), 1, 2, 4, 8 and 16 years. Blood was drawn at 4, 8 and 16 years. Sera were available for 64%, 60%, and 62% of the population. In 1699 children, 42% of the original cohort, blood samples were available from all three clinical follow ups (4, 8 and 16 years). In this group of children, a random subset of 800 was collected of which 778 had complete data on peanut allergy at 16 years and sufficient serum volumes for analysis, denoted as the population-based study group. For some of the analyses, this population-based study group was enriched with all remaining peanut extract-sensitized children (measured with ImmunoCAP (f13) at 4, 8 and/or 16 years of age) among the group of This resulted in 84 additional children for which complete peanut symptom data at 16 years of age and sufficient volume of serum for analysis were available. Thus, our peanut-enriched study group included 862 children (778 from the population-based study group enriched with 84 peanut sensitized children) (Figure E1). Permission for the study was obtained from the Regional Ethical Review board at Karolinska Institutet at each follow up and parents of participating children gave their informed consent. At 16 years, the participating teens gave their separate consent. Definition of symptoms All data on peanut symptoms were collected through questionnaires answered by the children s parents at 1, 2, 4, 8 and 16 years. Specific organ symptoms to peanut were asked at 8 and 16 years. Peanut allergy at 1, 2 and 4 years: Did your child ever have adverse reactions to food or drink, such as vomiting, diarrhea, eczema, nettle rash, itch or swelling of lips or eyelids, runny nose or asthma? ( Yes and peanut indicated). 1
24 Asarnoj et al Peanut allergy at 8 years: Any of the following symptoms to peanut indicated: Nose/Eye problems, Itching in mouth, Trouble breathing, Vomiting or diarrhea, Eczema, Nettle rash, Avoided foodstuff because of previous adverse reaction. Peanut allergy at 16 years: Any of the following symptoms to peanut indicated: Difficulty breathing, asthma, cough, Itchy nose, stuffy nose, runny nose, itchy eyes, Nettle rash covering most of the body, Nettle rash that covered less, Vomiting, stomach pain, Swelling in face, eyelids, lips, Hoarseness, indistinct speech, Swollen feeling in mouth, throat, Itch in mouth, throat, ears, Pronounced fatigue, decreased awareness and Unconsciousness. Individuals with a positive answer to Itch in mouth, throat, ears and negative to all other symptoms were regarded as having local symptoms only (Oral Allergy Syndrome=OAS). Systemic peanut symptoms were defined as at least one positive answer to Difficulty of breathing, asthma, cough or Nettle rash covering most of the body or Vomiting, stomach pain or Swelling in face, eyelids, lips or Hoarseness, indistinct speech or Pronounced fatigue, decreased awareness or Unconsciousness. Allergen-specific IgE measurement Serum samples were analyzed with ImmunoCAP (Thermo Fisher AB, Uppsala, Sweden) for allergenspecific IgE antibodies to peanut extract (f13) and at 8 years of age also to Ara h 2. A positive test was defined as 0.35 ku A /L. An IgE antibody level >100 ku A /L was given the value of 101 ku A /L in statistical evaluations and an IgE level <0.35 was set to 0. IgE reactivity to the peanut allergen molecules (Ara h 1, Ara h 2, Ara h 3, Ara h 6, Ara h 8 and Ara h 9) was analyzed using a modified allergen chip based on ISAC technology (Thermo Fisher) developed in the MeDALL FP7-funded research programme 2. The cut-off was set at 0.3 ISU-E. Biases The diagnosis of peanut allergy was based on clinical symptoms and no food challenge was carried out, since the different peanut allergy phenotypes in the study population were not yet known at sampling and, for logistic reasons, it was not possible to perform food challenges in all 862 participants. Sample size 53 No sample size was calculated as this is an exploratory study. 2
25 Asarnoj et al Statistical methods Results are expressed as numbers and proportions (%). T-test of proportions was used for comparison of prevalence rates between groups. Group IgE levels are expressed as median value and range. T-test on log-transformed values was used for group comparisons of IgE levels. Odds Ratios (ORs) for symptoms to peanut at 16 years in relation to sensitization at 4 and 8 years were estimated using logistic regression models and 95% confidence intervals. Fitted predicted probability estimates were plotted according to the IgE-level (ISU-E and ku A /L) to peanut allergen molecules or peanut extract (respectively) per participant, using the results from the logistic regression. The correlation factor (rho) between the IgE levels to Ara h 2 at 8 years measured with microarray and ImmunoCAP was high: A linear regression with ImmunoCAP and microarray Ara h 2 IgE levels was performed to calculate corresponding values. 95% OR CI not including 1 and p-values <0.05 were considered significant. Analysis with logistic regression in order to investigate peanut symptoms in relation to sensitization to different peanut allergen molecules could not be performed due to substantial co-sensitization between different peanut storage proteins. All statistical analyses were performed with STATA Statistical Software (release 14.0; StataCorp, College Station, Texas, USA). References 1. Wickman M, Kull I, Pershagen G, Nordvall SL. The BAMSE project: presentation of a prospective longitudinal birth cohort study. Pediatr Allergy Immunol 2002; 13 Suppl 15: Lupinek C, Wollmann E, Baar A, Banerjee S, Breiteneder H, Broecker BM, et al. Advances in allergen-microarray technology for diagnosis and monitoring of allergy: the MeDALL allergenchip. Methods 2014; 66:
26 Table E1. Prevalence of reported symptoms to peanut at 4, 8 and 16 years of age. Type of symptom specified at 8 and 16 years of age. N=778 (population based). 1 year 2 years 4 years 8 years 16 years Reported symptoms to peanut Sensitization to peanut extract Peanut symptomatic and sensitized to peanut extract Sensitization to peanut storage protein Peanut symptomatic and sensitized to peanut storage proteins Peanut systemic symptom(s) and sensitized to peanut storage proteins Type of symptom* 3/769(0.4%) 6/777 (0.8%) 24/760 (3.2%) n.a. n.a. 49/778 (6.3%) n.a. n.a. 17/760 (2.2%) n.a. n.a. 44/778 (5.7%) n.a. n.a. 17/760 (2.2%) 48/773 (6.2%) 53/778 (6.8%) 63/773 (8.2%) 61/778 (7.8%) 32/768 (4.2%) 32/778 (4.1%) 42/778 (5.8%) 48/778 (6.2%) 27/773 (3.5%) 30/778 (3.9%) n.a. n.a. n.a. 11/773 (1.4%) 23/778 (3.0%) p=0.03 Upper resp n.a. n.a. n.a. 9/28 (32.1%) 6/53 (11.3%) Oral cavity n.a. n.a. n.a. 14/28 (50.0%) 37/53 (69.8%) Lower resp n.a. n.a. n.a. 11/28 (39.3%) 20/53 (37.7%) Gastrointestinal n.a. n.a. n.a. 5/28 (17.9%) 9/53 (17.0%) Urticaria n.a. n.a. n.a. 8/28 (28.6%) 13/53 (24.5%) Circulatory n.a. n.a. n.a. n.a. 1/53 (1.9%) 2 systemic symptoms n.a. n.a. n.a. 4/28 (14.3%) 16/53 (30.2%) p=0.11 n.a.= information not available resp=respiratory *only 28 of the 48 peanut symptomatic children specified type of symptom at 8 years of age.
27 Table E2. Baseline (at median age 2 months) and age one year characteristics of the populationbased study group (N=778, number of missing values in each row: 0-7) and the peanut extract sensitized enriched study group (N=862, number of missing values: 0-12), compared to children in the original cohort (N=4089, number of missing values: 0-170). Variables Study base cohort (N=4089) Study population, population based (N=778) Additional peanut extract sensitized group (N=84) n % n % p-value n % p-value Female Parental history of allergy <0.01 Breastfed 4months Parental smoking Young mother at birth ( 25 years) White collar parent Older siblings
28 E-Figure legends Figure E1. Venn diagram showing the study population of 862 participants (indicated in pink) derived from the BAMSE cohort (N=4089): A subgroup of population-based participants (N=778) enriched with peanut extract sensitized participants (N=84) from the group of eligible participants (N=1699). Figure E2. Ara h 2/Ara h 6 sensitization overlap at 4, 8 and 16 years of age. Median IgE levels (ISU-E) in the sensitization subgroups. N=862 (peanut-enriched study group) Figure E3. Ara h 1/Ara h 2/Ara h 3 sensitization overlap at 4, 8 and 16 years of age. Median IgE levels (ISU-E) in the sensitization subgroups. N=862 (peanut-enriched study group) Figure E4. Likelihood of reporting symptoms to peanut at 16 years of age in relation to A) Ara h 2 IgE level at 4 years of age (ISU-E), B) Ara h 2 IgE level at 4 years of age (ISU-E) (incident symptoms), C) peanut extract IgE level at 4 years of age (ku A /L) or D) number of sensitizing peanut allergen molecules (Ara h 8 excluded)/ peanut extract sensitization at 4 years of age. N=862 (peanut-enriched study group)
Prediction of peanut allergy in adolescence by early childhood storage protein-specific IgE signatures: The BAMSE population-based birth cohort
VOLUME 140, NUMBER 2 LETTERS TO THE EDITOR 587 in a TLR4-dependent manner, to a greater extent than those impregnated with ASMCs from controls. Thus, HMGB1 could contribute to ASM dysfunction and airway
More informationAccepted Manuscript. Assessment of thunderstorm-induced asthma using Google Trends
Accepted Manuscript Assessment of thunderstorm-induced asthma using Google Trends Jean Bousquet, MD, Robyn E. O Hehir, MD, Josep M. Anto, MD, Genaro D Amato, MD, Ralf Mösges, MD, Peter W. Hellings, MD,
More informationAllerGen International Research Visit to Karolinska Institutet: Final Report
AllerGen International Research Visit to Karolinska Institutet: Final Report Prepared by: Laura Feldman, MPH Epidemiology candidate at the Dalla Lana School of Public Health, University of Toronto November
More informationPeanut component Ara h 8 sensitization and tolerance to peanut
Peanut component h 8 sensitization and tolerance to peanut Anna Asarnoj, MD, PhD, a,b,d Caroline Nilsson, MD, PhD, c,e Jonas Lidholm, PhD, f Susanne Glaumann, MD, c,e Eva Ostblom, MD, PhD, c,d,e Gunilla
More informationThe Utility of Peanut Components in the Diagnosis of IgE-Mediated Peanut Allergy Among Distinct Populations
The Utility of Peanut Components in the Diagnosis of IgE-Mediated Peanut Allergy Among Distinct Populations Jay A. Lieberman, MD a, *, Susanne Glaumann, MD b,c, Sofia Batelson, MD c, Magnus P. Borres,
More informationPrecise results for safe decisions. How to better define and manage peanut allergy
Precise results for safe decisions How to better define and manage peanut allergy Better risk assessment with allergen components How can you differentiate between true peanut allergy or symptoms caused
More informationEvaluation of basophil allergen threshold sensitivity (CD-sens) to peanut and Ara h 8 in children IgE-sensitized to Ara h 8
Glaumann et al. Clinical and Molecular Allergy (15) 13:5 DOI 1.1186/s12948-14-7-3 RESEARCH Open Access Evaluation of basophil allergen threshold sensitivity (CD-sens) to peanut and Ara h 8 in children
More informationThe asthma-rhinitis multimorbidity is associated with IgE polysensitization in adolescents and adults
The asthma-rhinitis multimorbidity is associated with IgE polysensitization in adolescents and adults Valérie Siroux, Natalia Ballardini, Marion Soler, Christian Lupinek, Anne Boudier, Isabelle Pin, Jocelyne
More informationResearch Article Peanut Sensitization Profiles in Italian Children and Adolescents with Specific IgE to Peanuts
BioMed Research International Volume 2013, Article ID 170452, 5 pages http://dx.doi.org/10.1155/2013/170452 Research Article Peanut Sensitization Profiles in Italian Children and Adolescents with Specific
More informationIs there a Role for Sensitization in Predicting Severity? Ronald van Ree Academic Medical Center University of Amsterdam
Is there a Role for Sensitization in Predicting Severity? Ronald van Ree Academic Medical Center University of Amsterdam A journey into the past, before this happened 2006 CRD using four purified apple
More informationHigh frequency of IgE sensitization towards kiwi seed storage proteins among peanut allergic individuals also reporting allergy to kiwi
DOI 10.1186/s12948-017-0073-4 Clinical and Molecular Allergy RESEARCH Open Access High frequency of IgE sensitization towards kiwi seed storage proteins among peanut allergic individuals also reporting
More informationDiscover the connection
Mike is about to have gastrointestinal symptoms, and his parents won t know why Milk Soy milk Wheat bread Egg FOOD ALLERGY Symptoms and food allergies Discover the connection ImmunoCAP Complete Allergens
More informationPeanut allergy: Clinical and immunologic differences among patients from 3 different geographic regions
Original articles Peanut allergy: Clinical and immunologic differences among patients from 3 different geographic regions Andrea Vereda, MD, PhD, a,b,c * Marianne van Hage, MD, PhD, d,e * Staffan Ahlstedt,
More informationappropriate olive pollen SIT
OLIVE POLLEN Molecular Allergology Use components to identify patients for appropriate olive pollen SIT Resolve multiple positivity to pollen tests Use components to resolve multiple positivity to pollen
More informationParental antibiotics and childhood asthma : a population-based study. Örtqvist, A.K.; Lundholma, C.; Fang, F.; Fall, T.; Almqvist, C.
This is an author produced version of a paper accepted by Journal of Allergy and Clinical Immunology. This paper has been peer-reviewed but does not include the final publisher proof-corrections or journal
More informationslge112 Molecular Allergology Product Characteristics ImmunoCAP ISAC slge 112
slge112 Molecular Allergology Product Characteristics ImmunoCAP ISAC slge 112 IMMUNOCAP ISAC 112 Contents Intended Use 1 Principle of test procedure 1 Clinical utility 1 Sample information 2 Measuring
More informationHeredity, pet ownership, and confounding control in a populationbased
Heredity, pet ownership, and confounding control in a populationbased birth cohort Catarina Almqvist, MD, PhD, a,b Ann-Charlotte Egmar, RN, a Marianne van Hage-Hamsten, MD, PhD, c Niklas Berglind, MSc,
More informationDiscover the connection
Emma is worried about having a systemic reaction, so she avoids all nuts Walnuts FOOD ALLERGY Hazelnuts Peanuts Systemic reactions and underlying proteins Discover the connection ImmunoCAP Complete Allergens
More informationJournal. ImmunoDiagnostics. 3 Overview. 5 CAPture. Scientific news, opinions and reports. Journal No
Journal No. 6. 2013 Scientific news, opinions and reports Journal ImmunoDiagnostics CAPture - study on new hazelnut components and more Two hazelnut storage protein components - Cor a 9 and Cor a 14 -
More informationt DSPAP s 9. årsmøde Sachs Children s Hospital Karolinska Institutet
Ef Erfaringer fra kohortestudier t DSPAP s 9. årsmøde Magnus Wickman Sachs Children s Hospital Karolinska Institutet Stockholm Study design Cross sectional studies, recall bias reversed causation error
More informationEarly-life supplementation of vitamins A and D, in water-soluble form or in peanut oil, and allergic diseases during childhood
Original articles Early-life supplementation of vitamins A and D, in water-soluble form or in peanut oil, and allergic diseases during childhood Inger Kull, RN, PhD, a,b,d Anna Bergström, PhD, b Erik Melén,
More informationImproving allergy outcomes. Allergen Component Testing. Jay Weiss Ph.D and Gary Kitos, Ph.D. H.C.L.D.
Improving allergy outcomes Allergen Component Testing Jay Weiss Ph.D and Gary Kitos, Ph.D. H.C.L.D. Allergen Component Testing Allergic disease is an immunologic response to an allergen or allergens that
More informationSchool Year SEVERE ALLERGY Medical Action Plan (MAP) Student s Name. Date of Birth CONTACT INFORMATION ALLERGIC HISTORY
Bus Transportation Office Use ONLY if Needed Bus # Driver Route # Medical File 9758 E Highland Rd. Howell, MI 48843 810-632-2200 phone 810-632-2201 fax School Year SEVERE ALLERGY Medical Action Plan (MAP)
More informationThreshold levels in food challenge and specific IgE in patients with egg allergy: Is there a relationship?
Threshold levels in food challenge and specific IgE in patients with egg allergy: Is there a relationship? Morten Osterballe, MD, and Carsten Bindslev-Jensen, MD, PhD, DSc Odense, Denmark Background: Previously
More informationIgE antibodies to allergen components
IgE antibodies to allergen components NY VERSION 2012 SACHS CHILDREN S SACHSSKA HOSPITAl, BARNSJUKHUSET, Stockholm South SÖDERSJUKHUSET General Hospital The contents of this leaflet are based on the authors
More informationWhich test is best for diagnosing peanut allergy in South African children with atopic dermatitis?
Which test is best for diagnosing peanut allergy in South African children with atopic dermatitis? C L Gray, 1 MB ChB, FRCPCH, MSc, PhD; M E Levin, 1 MB ChB, FCPaeds, PhD; G du Toit, 2 MB ChB, FRCPCH 1
More informationDiagnosing peanut allergy with skin prick and specific IgE testing
Diagnosing peanut allergy with skin prick and specific IgE testing Graham Roberts, DM, Gideon Lack, FRCPCH, and the Avon Longitudinal Study of Parents and Children Study Team London, United Kingdom Background:
More informationExposure to environmental tobacco smoke and sensitisation in children
1 Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden; 2 Department of Paediatrics, Karolinska University Hospital, Huddinge, Sweden; 3 Department of Paediatrics, Sach s Children
More informationPatterns of sensitization to peanut allergen components in Taiwanese Preschool children
Journal of Microbiology, Immunology and Infection (2012) 45, 90e95 Available online at www.sciencedirect.com journal homepage: www.e-jmii.com ORIGINAL ARTICLE Patterns of sensitization to peanut allergen
More informationOnline Data Supplement. Early life exposure to traffic-related air pollution and lung function in adolescence
Online Data Supplement Early life exposure to traffic-related air pollution and lung function in adolescence Authors: Erica S. Schultz MD, Jenny Hallberg PhD, Prof Tom Bellander PhD, Anna Bergström PhD,
More informationFood Allergy Advances in Diagnosis
22 nd World Allergy Congress Food Allergy Advances in Diagnosis By: Hugh A. Sampson, M.D. Food Allergy Advances in Diagnosis Hugh A. Sampson, M.D. Professor of Pediatrics & Immunology Dean for Translational
More informationMolecular diagnosis and the Italian Board for ISAC
R E V I E W Eur Ann Allergy Clin Immunol Vol 46, N 2, 68-73, 2014 E. Nettis 1, F. Bonifazi 2, S. Bonini 3, E. Di Leo 1,4, E. Maggi 5, G. Melioli 6, G. Passalacqua 7, G. Senna 8, M. Triggiani 9, A. Vacca
More informationThe association between Chlamydia pneumoniae antibodies and wheezing in young children and the influence of sex
Thorax Online First, published on August 23, 2006 as 10.1136/thx.2005.051656 The association between Chlamydia pneumoniae antibodies and wheezing in young children and the influence of sex Erik Normann
More informationSupplementary appendix
Supplementary appendix This appendix formed part of the original submission and has been peer reviewed. We post it as supplied by the authors. Supplement to: Pinart M, Benet M, Annesi-Maesano I, et al.
More informationMolecular diagnosis of peanut and legume allergy Nicolaos Nicolaou and Adnan Custovic
Molecular diagnosis of peanut and legume allergy Nicolaos Nicolaou and Adnan Custovic The University of Manchester, Manchester Academic Health Science Centre, NIHR Translational Research Facility in Respiratory
More informationAuthor s response to reviews
Author s response to reviews Title: The epidemiologic characteristics of healthcare provider-diagnosed eczema, asthma, allergic rhinitis, and food allergy in children: a retrospective cohort study Authors:
More informationSerum levels of Clara cell secretory protein, asthma, and lung function in the adult general population
Postprint Version Journal website Pubmed link DOI 1.0 http://www.jacionline.org/article/s0091-6749(13)00162-0/abstract http://www.ncbi.nlm.nih.gov/pubmed/23473837 10.1016/j.jaci.2013.01.023 Serum levels
More informationEczema: also called atopic dermatitis; a chronic, itchy, scaly rash not due to a particular substance exposure
Allergy is a condition in which the immune system causes sneezing, itching, rashes, and wheezing, or sometimes even life-threatening allergic reactions. The more you know about allergies, the better prepared
More informationPediatric Allergy, Asthma & Immunology Jackee D. Kayser, M.D. Howard M. Rosenblatt, M.D. NEW PATIENT QUESTIONNAIRE
Page 1 of 5 Pediatric Allergy, Asthma & Immunology Jackee D. Kayser, M.D. Howard M. Rosenblatt, M.D. NEW PATIENT QUESTIONNAIRE NAME: AGE: DATE OF BIRTH: Primary/Referring Physician: Phone #: Other Subspecialists
More informationUK NEQAS survey of allergen component testing across the United Kingdom and other European countries
Clinical and Experimental Immunology ORIGINAL ARTICLE doi:10.1111/cei.12950 UK NEQAS survey of allergen component testing across the United Kingdom and other European countries R. Saleem,* C. Keymer,*
More informationDiscover the connection
Susan lives with daily rhinitis symptoms. Pollen House dust mites Timothy grass Underlying allergens affect rhinitis Discover the connection Specific IgE blood testing helps you identify allergic triggers,
More informationAllergic Rhinitis: Effects on Quality of Life and Co-morbid Conditions
Disclosures : Effects on Quality of Life and Co-morbid Conditions Nycomed Pharmaceutical Sepracor Pharmaceutical Michael S. Blaiss, MD Clinical Professor of Pediatrics and Medicine University of Tennessee
More informationDevelopment and comorbidity of eczema, asthma and rhinitis to age 12: data from the BAMSE birth cohort. Allergy Apr;67(4):
This is an author produced version of a paper accepted by Allergy. This paper has been peer-reviewed but does not include the final publisher proof-corrections or journal pagination. Development and comorbidity
More informationIntroduction. Methods. Results 12/7/2012. Immunotherapy in the Pediatric Population
12/7/212 Introduction Immunotherapy in the Pediatric Population Michael S. Blaiss, MD Clinical Professor of Pediatrics and Medicine University of Tennessee Health Science Center Memphis, Tennessee Allergen
More informationNEW PATIENT INTAKE FORM
NEW PATIENT INTAKE FORM NAME: DOB: SEX: MALE FEMALE ADDRESS: ZIP CODE: PHONE #: - - WORK#: - - PHARMACY: PHARMACY #: - - WOULD YOU BE INTERESTED IN HAVING ACCESS TO YOUR MEDICAL RECORDS ONLINE? YES / NO
More informationClinical Study Phadiatop Infant in the Diagnosis of Atopy in Children with Allergy-Like Symptoms
International Pediatrics Volume 2009, Article ID 460737, 4 pages doi:10.1155/2009/460737 Clinical Study Phadiatop Infant in the Diagnosis of Atopy in Children with Allergy-Like Symptoms Ragnhild Halvorsen,
More informationParental smoking and development of allergic sensitization from birth to adolescence
Allergy ORIGINAL ARTICLE EPIDEMIOLOGY AND GENETICS Parental smoking and development of allergic sensitization from birth to adolescence J. D. Thacher 1, O. Gruzieva 1, G. Pershagen 1,2, A. Neuman 1,3,
More informationReply: Gut microbiota diversity and atopic disease: Does breast-feeding play a role?
Reply: Gut microbiota diversity and atopic disease: Does breast-feeding play a role? Thomas Abrahamsson, Hedvig E. Jakobsson, Anders F. Andersson, Bengt Bjorksten, Lars Engstrand and Maria Jenmalm Linköping
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. GRAZAX 75,000 SQ-T oral lyophilisate
PACKAGE LEAFLET: INFORMATION FOR THE USER GRAZAX 75,000 SQ-T oral lyophilisate Standardised allergen extract of grass pollen from Timothy (Phleum pratense) Read all of this leaflet carefully before you
More informationMechanismen der allergenspezifischen Immuntherapie
Mechanismen der allergenspezifischen Immuntherapie Medizinische Universität Wien Zentrum für Pathophysiologie, Infektiologie und Immunologie Institut für Pathophysiologie und Allergieforschung Abteilung
More informationR espiratory tract infections are well recognised as triggers
1054 ASTHMA Association between Chlamydia pneumoniae antibodies and wheezing in young children and the influence of sex E Normann, J Gnarpe, B Wettergren, C Janson, M Wickman, L Nordvall... See end of
More informationThe Quest for Clinical Relevance
Allergy Testing in Laboratory The Quest for Clinical Relevance 1989 20130 3 1989 A Good Year Current Concepts Lecture Allergy 1989 a good year WHY ME? Current Concepts Lecturers 1989 Andrew Wootton David
More informationAccepted Manuscript. Overall and Subgroup Prevalence of Acne Vulgaris Among Patients with Hidradenitis Suppurativa
Accepted Manuscript Overall and Subgroup Prevalence of Acne Vulgaris Among Patients with Hidradenitis Suppurativa Sara Wertenteil, BA, Andrew Strunk, MA, Amit Garg, MD PII: S01909622(18)329128 DOI: https://doi.org/10.1016/j.jaad.2018.11.022
More informationCommonwealth of Massachusetts Department of Early Education and Care
Commonwealth of Massachusetts Department of Early Education and Care MEDICATION CONSENT FORM 606 CMR 7.11(2)(b) Name of child: Name of medication: Please one of the following: Prescription: Oral/Non-Prescription:
More informationExploring the temporal development of childhood IgE profiles to allergen components
Önell et al. Clinical and Translational Allergy 2012, 2:24 RESEARCH Open Access Exploring the temporal development of childhood IgE profiles to allergen components Annica Önell 1, Lisbeth Hjälle 2 and
More informationEczema in childhood and adolescence
From the Department of Medicine Solna, Dermatology and Venereology Unit Karolinska Institutet, Stockholm, Sweden Eczema in childhood and adolescence Emma Johansson Stockholm 2017 All previously published
More informationFood hypersensitivity among schoolchildren
Food hypersensitivity among schoolchildren prevalence, Health Related Quality of Life and experiences of double-blind placebo-controlled food challenges. OLIN PhD Thesis XVIII Åsa Strinnholm, PhD ¹/ Allergikonsulent
More informationEffects of the the EPI (Extraction of Pathological Information) treatment method on grass pollen allergy and dairy product intolerance
Clinical study report Effects of the the EPI (Extraction of Pathological Information) treatment method on grass pollen allergy and dairy product intolerance Final report established by: Christian P. Bouillaguet,
More informationPatient (Parent) Questionnaire Patient s Name: DOB: Date: Referred By: Primary Care Physician:
Dr. Bina Joseph Patient (Parent) Questionnaire Patient s Name: DOB: Date: Referred By: Primary Care Physician: Describe each problem that has led you to seek this allergy evaluation: 1. 2. 3. 4. Drug Allergies:
More informationIntegrated Allergy and Asthma Prevention and Care: Report of the MeDALL/AIRWAYS ICPs Meeting at the Ministry of Health and Care Services, Oslo, Norway
Brief Report Received: January 29, 2015 Accepted after revision: May 13, 2015 Published online: Integrated Allergy and Asthma Prevention and Care: Report of the MeDALL/AIRWAYS ICPs Meeting at the Ministry
More informationTODAY S DATE: AN: WHAT IS THE REASON
NEW PATIENTT HISTORY QUESTIONNAIRE Please complete this entire questionnaire as best you can and hand this completed packet to the Medical Assistant when you are called back. This packet willl inform us
More informationSANTA MONICA BREAST CENTER INTAKE FORM
SANTA MONICA BREAST CENTER Who referred you to see us today? Who is your primary care physician? Are there any other MDs who you would like to receive today s visit information? No Yes MD contact info
More informationDiagnostic Value of Specific IgE to Peanut and Ara h 2 in Korean Children with Peanut Allergy
Original Article Allergy Asthma Immunol Res. 2016 March;8(2):156-160. http://dx.doi.org/10.4168/aair.2016.8.2.156 pissn 2092-7355 eissn 2092-7363 Diagnostic Value of Specific IgE to and Ara h 2 in Korean
More informationUse of multivitamin supplements in relation to allergic disease in 8-y-old children 1 3
AJCN. First published ahead of print October 28, 2009 as doi: 10.3945/ajcn.2009.27963. Use of multivitamin supplements in relation to allergic disease in 8-y-old children 1 3 Kristin Marmsjö, Helen Rosenlund,
More informationSTUDENT HEALTH FORM. Name of Student Birth Date Sex (MM/DD/YY) Entrance Date (MM/DD/YY) Siblings in the School (names and grades)
STUDENT HEALTH FORM If you are a new student enrolling at AISC, please attach a copy of the immunization records & proof of physical exam in the last 12 months & submit the complete form to: Sanja Ilic,
More informationEPIPEN INSERVICE Emergency Administration of Epinephrine for the Basic EMT. Michael J. Calice MD, FACEP St. Mary Mercy Hospital
EPIPEN INSERVICE Emergency Administration of Epinephrine for the Basic EMT Michael J. Calice MD, FACEP St. Mary Mercy Hospital Case #1 NR is an 8 yo male c/o hot mouth and stomach ache after eating jelly
More informationPath2220 INTRODUCTION TO HUMAN DISEASE ALLERGY. Dr. Erika Bosio
Path2220 INTRODUCTION TO HUMAN DISEASE ALLERGY Dr. Erika Bosio Research Fellow Centre for Clinical Research in Emergency Medicine, Harry Perkins Institute of Medical Research University of Western Australia
More informationMEDICAL QUESTIONNAIRE (male)
MEDICAL QUESTIONNAIRE (male) Slievemore Clinic, Old Dublin Road, Stillorgan, Co. Dublin. Tel 01-2000501/502 Fax: 01 2780248 The appointment comprises of a discussion about this questionnaire and a subsequent
More informationClinical and patient based evaluation of immunotherapy for grass pollen and mite allergy
Clinical and patient based evaluation of immunotherapy for grass pollen and mite allergy K. Dam Petersen a, D. Gyrd-Hansen a, S. Kjærgaard b and R. Dahl c a Health Economics, Institute of Public Health,
More informationEarly Teen Interview
I. STUDY NUMBER II. EVENT II. TODAY S DATE / / III. RA INITIALS IV. SITE 1 KENMORE 2 HOME 9 OTHER Early Teen Interview Okay, great. So, let s start the interview. I d like to begin by stressing that there
More informationClinical & Experimental Allergy
doi: 10.1111/cea.12340 Clinical & Experimental Allergy, 45, 283 291 ORIGINAL ARTICLE Epidemiology of Allergic Disease 2014 The Authors. Clinical & Experimental Allergy Published by John Wiley & Sons Ltd.
More informationGo molecular! A clinical reference guide to molecular allergy Part 1: The basics. Second edition By Neal Bradshaw
Setting the standard in allergy diagnostics Go molecular! A clinical reference guide to molecular allergy Part 1: The basics Second edition By Neal Bradshaw For more information on this topic allergyai.com
More informationPAGE 1 NEURO-OPHTHALMIC QUESTIONNAIRE NAME: AGE: DATE OF EXAM: CHART #: (Office Use Only)
PAGE 1 NEURO-OPHTHALMIC QUESTIONNAIRE NAME: AGE: DATE OF EXAM: CHART #: (Office Use Only) 1. What is the main problem that you are having? (If additional space is required, please use the back of this
More informationTo: Parents & Guardians of Students in Franklin County Schools
Florida Department of Health in Franklin County School Health Program To: Parents & Guardians of Students in Franklin County Schools Date: 10/1/18 RE: 2018/2019 Influenza Vaccine (Flu shots) This year,
More informationPrescribing Framework for Sublingual Immunotherapy (Grazax)
Hull & East Riding Prescribing Committee Prescribing Framework for Sublingual Immunotherapy (Grazax) Patient s Name:.. NHS Number: Patient s Address:... (Use addressograph sticker) GP s Name:... Communication
More informationShould you have questions or concerns, please contact the Program Supervisor at the location your child is registered.
Community Services Department, Recreation Division 201 City Centre Drive MISSISSAUGA ON L5B 2T4 mississauga.ca/recreation Dear Parent/Guardian, We are excited to have you join us for camps this season!
More informationThe diagnostic value of componentresolved diagnostics in peanut allergy in children attending a Regional Paediatric Allergology Clinic
van Veen et al. BMC Pediatrics (206) 6:74 DOI 0.86/s2887-06-0609-7 RESEARCH ARTICLE Open Access The diagnostic value of componentresolved diagnostics in peanut allergy in children attending a Regional
More informationIgE recognition patterns in peanut allergy are age dependent: perspectives of the EuroPrevall study
Allergy ORIGINAL ARTICLE EXPERIMENTAL ALLERGY AND IMMUNOLOGY IgE recognition patterns in peanut allergy are age dependent: perspectives of the EuroPrevall study B. K. Ballmer-Weber 1, J. Lidholm 2, M.
More informationNOTE: Do not depend on antihistamines or inhalers (bronchodilators) to treat a severe reaction. USE EPINEPHRINE.
Name: Allergy to: Weight: D.O.B.: lbs. Asthma: [ ] Yes (higher risk for a severe reaction) [ ] No PICTURE NOTE: Do not depend on antihistamines or inhalers (bronchodilators) to treat a severe reaction.
More informationAllergy Management Policy
Allergy Management Policy Food Allergy People with allergies have over-reactive immune systems that target otherwise harmless elements of our diet and environment. During an allergic reaction to food,
More informationAccepted Manuscript. Prebiotics Versus Low Fodmap Diet: An Interpretative Nightmare. Jane Varney, Jane G. Muir, Peter R. Gibson
Accepted Manuscript Prebiotics Versus Low Fodmap Diet: An Interpretative Nightmare Jane Varney, Jane G. Muir, Peter R. Gibson PII: S0016-5085(18)35389-7 DOI: https://doi.org/10.1053/j.gastro.2018.10.060
More informationReal-Life Study for the Diagnosis of House Dust Mite Allergy The Value of Recombinant Allergen-Based IgE Serology
Original Paper Int Arch Allergy Immunol 2016;1:132 137 Received: February 29, 2016 Accepted after revision: June 15, 2016 Published online: August 10, 2016 Real-Life Study for the Diagnosis of House Dust
More informationMonitoring of peanut-allergic patients with peanut-specific IgE
Monitoring of peanut-allergic patients with peanut-specific IgE Rozita Borici-Mazi, M.D., Jorge A. Mazza, M.D., David W. Moote, M.D., and Keith B. Payton, M.D. ABSTRACT Peanut allergy affects 1% of the
More informationMEDICAL QUESTIONNAIRE (female)
MEDICAL QUESTIONNAIRE (female) Slievemore Clinic, Old Dublin Road, Stillorgan, Co. Dublin. Tel 01-2000501 The appointment comprises of a discussion about this questionnaire and a subsequent medical examination.
More informationINDIVIDUAL CARE REGISTRATION MATERIALS
INDIVIDUAL CARE REGISTRATION MATERIALS Individual Care Plan Medication Treatment Form Emergency & Allergy Action Plans Food Allergy/Intolerance Health Care Provider Statement YMCA OF SNOHOMISH COUNTY ymca-snoco.org
More informationRand E. Dankner, M.D. Jacqueline L. Reiss, M. D.
Tips to Remember: Food allergy Up to 2 million, or 8%, of children, and 2% of adults in the United States are estimated to have food allergies. With a true food allergy, an individual's immune system will
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Burks AW, Jones SM, Wood RA, et al. Oral immunotherapy for
More informationThe legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 21 July 2010
The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION 21 July 2010 GRAZAX 75 000 SQ-T, oral lyophilisate B/30 (CIP: 378 011-6) B/100 (CIP code: 378 012-2) B/90 (CIP code:
More informationPediatric Allergy Allergy Related Testing
Pediatric Allergy Allergy Related Testing 1 Allergies are reactions that are usually caused by an overactive immune system. These reactions can occur in a variety of organs in the body, resulting in conditions
More informationHypersensitivity Reactions and Peanut Component Testing 4/17/ Mayo Foundation for Medical Education and Research. All rights reserved.
1 Hello everyone. My name is Melissa Snyder, and I am the director of the Antibody Immunology Lab at the Mayo Clinic in Rochester, MN. I m so glad you are able to join me for a brief discussion about the
More informationREQUIREMENTS FOR DEVELOPING AN INDIVIDUALIZED HEALTHCARE PLAN FOR STUDENTS WITH FOOD AND LIFE THREATENING ALLERGIES
REQUIREMENTS FOR DEVELOPING AN INDIVIDUALIZED HEALTHCARE PLAN FOR STUDENTS WITH FOOD AND LIFE THREATENING ALLERGIES Parent/ Guardian: Notify the appropriate school personnel of all student allergies and
More informationWhere There Is No Doctor 2017
DOSAGE BLANKS for giving medicines to those who cannot read (see p. 64) DOSAGE BLANKS for giving medicines to those who cannot read (see p. 64) DOSAGE BLANKS for giving medicines to those who cannot
More informationAmarillo Surgical Group Doctor: Date:
Office Visit Information (General Surgery) Amarillo Surgical Group Doctor: Date: Patient s Information Name: Last First Middle Social Security #: Date of Birth: Age Gender: [ Male / Female ] Marital Status:
More informationIs Early Exposure to Allergens Protective? Adnan Custovic MSc DM MD PhD Professor of Allergy North West Lung Centre Manchester, UK
Is Early Exposure to Allergens Protective? Adnan Custovic MSc DM MD PhD Professor of Allergy North West Lung Centre Manchester, UK Highest Sensitisation Rate With Moderate Dose Antigen Exposure Anti-KLH
More informationTREATMENT OF ANAPHYLACTIC REACTION WITH EPINEPHRINE
TREATMENT OF ANAPHYLACTIC REACTION WITH EPINEPHRINE FILE: JGCDC Background: The Bibb County School System recognizes the growing concern with severe life-threatening allergic reactions to food items, latex,
More informationConcept paper on a Guideline for allergen products development in moderate to low-sized study populations
1 2 3 4 5 6 7 13 December 2018 EMA/CHMP/251023/2018 Rheumatology / Immunology Working Party (RIWP) Concept paper on a Guideline for allergen products development in moderate to low-sized study populations
More informationPast Medical History. Chief Complaint: Patient Name: Appointment Date: Page 1
Appointment Date: Page 1 Chief Complaint: (Please write reason, symptoms, condition or diagnosis that prompts your appointment) Past Medical History PERSONAL SKIN HISTORY YES NO Yes - Details Melanoma
More informationASPECTS OF ECZEMA IN CHILDHOOD
From the Institute of Environmental Medicine Karolinska Institutet, Stockholm, Sweden ASPECTS OF ECZEMA IN CHILDHOOD Natalia Ballardini Stockholm 2013 All previously published papers were reproduced with
More informationManaging Allergies and Anaphylaxis at School EPI-PEN TRAINING FOR SCHOOL PERSONNEL
Managing Allergies and Anaphylaxis at School EPI-PEN TRAINING FOR SCHOOL PERSONNEL Objective: Attendees will be able to: Increase their knowledge about allergies to food and other allergens. Describe the
More informationCONTINUATION OF IMMUNOTHERAPY INJECTIONS AT RIDER UNIVERSITY ALLERGIST INFORMATION AND PERMISSION FORM
CONTINUATION OF IMMUNOTHERAPY INJECTIONS AT RIDER UNIVERSITY ALLERGIST INFORMATION AND PERMISSION FORM Dear Allergist: Your patient,, would like to continue allergy injections in our health center while
More information